Similarly, Vorinostat, a histone deacetylase (HDAC) inhibitor, has shown antitumor effects in GBM models by upregulating pro-apoptotic genes and downregulating cell cycle-related proteins51,52. Here, HDAC9 is linked to glioblastoma.